Commentary on the impact of the COVID-19 passports in Lithuania
- PMID: 36563968
- PMCID: PMC9764688
- DOI: 10.1016/j.jinf.2022.12.013
Commentary on the impact of the COVID-19 passports in Lithuania
Abstract
Conflict of interest statement
Declaration of Competing Interest The authors have no competing interests.
Figures
Comment in
-
Authors' reply to a commentary on the potential impact of COVID-19 passports to epidemiological situation.J Infect. 2023 Sep;87(3):e51-e53. doi: 10.1016/j.jinf.2023.06.010. Epub 2023 Jun 15. J Infect. 2023. PMID: 37329904 Free PMC article. No abstract available.
Comment on
-
Evaluating the potential impact of COVID-19 passports in Lithuania.J Infect. 2022 Sep;85(3):334-363. doi: 10.1016/j.jinf.2022.05.039. Epub 2022 Jun 1. J Infect. 2022. PMID: 35659544 Free PMC article. No abstract available.
References
-
- Commission Implementing Decision C(2022) 7948 of 28.10.2022 amending the marketing authorisation granted by Decision C(2022) 7342 for “Comirnaty - tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)”, (2022) 7948 of 28 Oct 2022, Annex I (Summary of Product Characteristics). Brussels: European Commission; https://ec.europa.eu/health/documents/community-register/2022/2022102815....
-
- A. Singanayagam, S. Hakki, J. Dunning, K.J. Madon, M.A. Crone, A. Koycheva. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis 2022 Feb;22(2):183-195. doi:10.1016/S1473-3099(21)00648-4. - DOI - PMC - PubMed
-
- UK Health Security Agency . UK Health Security Agency; 2022. COVID-19 Vaccine surveillance report. Week 13. 31 March Available at.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
